sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
BCAX
Updated 10/6/2026, 11:57 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| BCAX Bicara Therapeutics Inc. | Sale | $400,716 | Cohlhepp Ryan President, COO & Interim CEO, Director | 17,500 sh | at $22.90 | Filed Sep 10, 4:23 PM ET | Filing | |
| BCAX Bicara Therapeutics Inc. | Sale | $349,591 | Hyep Ivan Chief Financial Officer | 12,500 sh | at $27.97 | Filed Aug 12, 4:19 PM ET | Filing | |
| BCAX Bicara Therapeutics Inc. | Sale | $279,750 | Mazumdar Claire Chief Executive Officer, Director | 10,000 sh | at $27.98 | Filed Aug 12, 4:19 PM ET | Filing | |
| BCAX Bicara Therapeutics Inc. | Sale | $524,533 | Cohlhepp Ryan President and COO, Director | 18,750 sh | at $27.98 | Filed Aug 12, 4:19 PM ET | Filing | |
| BCAX Bicara Therapeutics Inc. | Sale | $284,198 | Mazumdar Claire Chief Executive Officer, Director | 10,000 sh | at $28.42 | Filed Jul 14, 4:22 PM ET | Filing | |
| BCAX Bicara Therapeutics Inc. | Sale | $833,129 | Cohlhepp Ryan President and COO, Director | 28,750 sh | at $28.98 | Filed Jul 10, 4:10 PM ET | Filing | |
| BCAX Bicara Therapeutics Inc. | Sale | $807,672 | Hyep Ivan Chief Financial Officer | 28,000 sh | at $28.85 | Filed Jul 10, 4:10 PM ET | Filing |